| Literature DB >> 27984724 |
Yen-Sin Ang1, Renee N Rivas1, Alexandre J S Ribeiro2, Rohith Srivas3, Janell Rivera4, Nicole R Stone1, Karishma Pratt4, Tamer M A Mohamed1, Ji-Dong Fu4, C Ian Spencer4, Nathaniel D Tippens5, Molong Li4, Anil Narasimha3, Ethan Radzinsky4, Anita J Moon-Grady6, Haiyuan Yu5, Beth L Pruitt2, Michael P Snyder3, Deepak Srivastava7.
Abstract
Mutation of highly conserved residues in transcription factors may affect protein-protein or protein-DNA interactions, leading to gene network dysregulation and human disease. Human mutations in GATA4, a cardiogenic transcription factor, cause cardiac septal defects and cardiomyopathy. Here, iPS-derived cardiomyocytes from subjects with a heterozygous GATA4-G296S missense mutation showed impaired contractility, calcium handling, and metabolic activity. In human cardiomyocytes, GATA4 broadly co-occupied cardiac enhancers with TBX5, another transcription factor that causes septal defects when mutated. The GATA4-G296S mutation disrupted TBX5 recruitment, particularly to cardiac super-enhancers, concomitant with dysregulation of genes related to the phenotypic abnormalities, including cardiac septation. Conversely, the GATA4-G296S mutation led to failure of GATA4 and TBX5-mediated repression at non-cardiac genes and enhanced open chromatin states at endothelial/endocardial promoters. These results reveal how disease-causing missense mutations can disrupt transcriptional cooperativity, leading to aberrant chromatin states and cellular dysfunction, including those related to morphogenetic defects.Entities:
Keywords: GATA4; TBX5; birth defect; cardiomyopathy; congenital heart defects; disease modeling; epigenetics; gene regulation; heart development; systems biology
Mesh:
Substances:
Year: 2016 PMID: 27984724 PMCID: PMC5180611 DOI: 10.1016/j.cell.2016.11.033
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 66.850